National Rare Disease Strategies: The Current State for Orphan Drug Market Access in European Union (Eu) Member States
Value Health
.
2014 Nov;17(7):A418.
doi: 10.1016/j.jval.2014.08.1016.
Epub 2014 Oct 26.
Authors
J Scholten
1
,
X Lie
1
,
A Kalbasko
1
,
J Maervoet
1
Affiliation
1
Quintiles Consulting, Hoofddorp, The Netherlands.
PMID:
27201053
DOI:
10.1016/j.jval.2014.08.1016
No abstract available